Search - tctmd.com

Displaying 81 - 100 of 100

Sort: Relevancy | Date

News Conference News TCT 2012

DAPT Cessation Within 1 Year Increased Risk for Major Adverse Events

October 23, 2012

Presentation TCT 2012

Position 2. If PCI Is Required, Use BMS for Low-Risk TVR Lesions!

Presenter: John Spertus

October 22, 2012

Presentation TCT 2012

Neoatherosclerosis After BMS and DES: Pathologic Insights

Presenter: Renu Virmani

October 22, 2012

Presentation TCT 2012

Neoatherosclerosis After BMS and DES: Experimental Insights

Presenter: Greg Kaluza

October 22, 2012

Presentation TCT 2012

DES vs. BMS in STEMI: Why Is This Such a Difficult Decision?

Presenter: Giuseppe De Luca

October 22, 2012

Presentation TCT 2012

Case Presentation (with Discussion): DES vs. BMS vs. OMT in Stable Ischemic Heart Disease

Presenter: Frederick Feit

October 22, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 22, 2012

News Conference News TCT 2012

Meta-Analyses Show Improved Outcomes with DES vs. BMS

October 22, 2012

News Conference News TCT 2012

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

November 09, 2011

News Conference News

Polymer-free DES Shown Effective in Multiple Trials

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

Efficacy of SES for In-stent Restenosis Dependent on Original Stent Type

November 07, 2011

News Conference News

DES and Stent Thrombosis Revisited

November 07, 2011

News Conference News

GHOST: Accurate Medical History May Predict DAPT Adherence in PCI for STEMI

November 06, 2011

News Conference News

Evidence of Late Catch-up After DES ‘Unequivocal’

November 06, 2011

News Conference News

DES Noninferior for Survival Compared with BMS in STEMI

November 06, 2011

Advertisement

DAPT Cessation Within 1 Year Increased Risk for Major Adverse Events

Position 2. If PCI Is Required, Use BMS for Low-Risk TVR Lesions!

Neoatherosclerosis After BMS and DES: Pathologic Insights

Neoatherosclerosis After BMS and DES: Experimental Insights

DES vs. BMS in STEMI: Why Is This Such a Difficult Decision?

Case Presentation (with Discussion): DES vs. BMS vs. OMT in Stable Ischemic Heart Disease

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Meta-Analyses Show Improved Outcomes with DES vs. BMS

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

COURAGE, FAME: Revascularization More Effective Than OMT

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

Polymer-free DES Shown Effective in Multiple Trials

Low Event Rates with EES Sustained at 2 Years

Efficacy of SES for In-stent Restenosis Dependent on Original Stent Type

DES and Stent Thrombosis Revisited

GHOST: Accurate Medical History May Predict DAPT Adherence in PCI for STEMI

Evidence of Late Catch-up After DES ‘Unequivocal’

DES Noninferior for Survival Compared with BMS in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content